Brief: Adaptive Biotechnologies Q1 EPS USD -0.13
05/05/2026 21:05
May 05 (Reuters) - Adaptive Biotechnologies Q1 revenue USD 70.874 million vs. IBES estimate USD 60.9 million. Q1 net income USD -20.015 million Q1 operating income USD -19.206 million Q1 operating expenses USD 90.08 million Q1 adjusted EBITDA USD -2.5 million vs. IBES estimate USD -6.55 million
Recent news on Adaptive Biotechnologies
See all newsAdvisory: Alert incorrectly tagged to Adaptive Biotechnologies withdrawn
U.S. RESEARCH ROUNDUP-Cloudflare, Replimune, Walmart
U.S. RESEARCH ROUNDUP-Equinix, Meta, S&P Global
Adaptive Biotechnologies Corp reports results for the quarter ended June 30 - Earnings Summary
Adaptive Biotechnologies Q2 revenue rises 22%, beats estimates